Jonathan Rosenberg
Overview
Explore the profile of Jonathan Rosenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
4281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamidi H, Senbabaoglu Y, Beig N, Roels J, Manuel C, Guan X, et al.
Cancer Cell
. 2024 Nov;
42(12):2098-2112.e4.
PMID: 39577421
Checkpoint inhibitors targeting programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) have revolutionized cancer therapy across many indications including urothelial carcinoma (UC). Because many patients do not benefit, a...
2.
Hussain K, Sam R, Patel R, Nso N, Singh L, Nazari J, et al.
J Cardiovasc Electrophysiol
. 2024 Sep;
35(11):2202-2210.
PMID: 39319519
Introduction: Left atrial appendage occlusion (LAAO) can be performed using diverse anesthetic approaches ranging from moderate sedation (MS) to general anesthesia (GA), and guided by intracardiac echocardiography (ICE) or transesophageal...
3.
Akin O, Lema-Dopico A, Paudyal R, Konar A, Chenevert T, Malyarenko D, et al.
Cancers (Basel)
. 2023 Nov;
15(22).
PMID: 38001728
This review focuses on the principles, applications, and performance of mpMRI for bladder imaging. Quantitative imaging biomarkers (QIBs) derived from mpMRI are increasingly used in oncological applications, including tumor staging,...
4.
LoCastro E, Paudyal R, Konar A, LaViolette P, Akin O, Hatzoglou V, et al.
Tomography
. 2023 Nov;
9(6):2052-2066.
PMID: 37987347
There is a need to develop user-friendly imaging tools estimating robust quantitative biomarkers (QIBs) from multiparametric (mp)MRI for clinical applications in oncology. Quantitative metrics derived from (mp)MRI can monitor and...
5.
Brenner D, Dorn S, Fogel R, Christie J, Laitman A, Rosenberg J
Int J Gen Med
. 2023 Aug;
16:3769-3777.
PMID: 37649852
Purpose: Patients with irritable bowel syndrome with constipation (IBS-C) experience abdominal pain with altered bowel movements. Plecanatide is indicated as IBS-C treatment in adults. This integrated analysis further characterizes plecanatide...
6.
Rosenberg J, Ritter T
Expert Rev Anti Infect Ther
. 2023 Jun;
21(7):687-690.
PMID: 37343183
No abstract available.
7.
Rosenberg J, Reddy M, Seelam P, Li O, Twal J, Pack J
Pancreas
. 2023 Apr;
51(10):1308-1314.
PMID: 37099771
Objectives: This retrospective real-world data analysis assessed clinical/health care professional characteristics of gastrointestinal symptom profiles in pancrelipase-treated patients with exocrine pancreatic insufficiency symptoms and chronic pancreatitis (CP) or type 2...
8.
McGregor B, ODonnell P, Balar A, Petrylak D, Rosenberg J, Yu E, et al.
Eur Urol
. 2022 Feb;
81(5):515-522.
PMID: 35168844
Background: The EV-201 trial (NCT03219333) demonstrated a clinically meaningful and durable response rate and a tolerable safety profile with enfortumab vedotin (EV) in patients with locally advanced/metastatic urothelial carcinoma (LA/mUC)...
9.
Leiman D, Cardona D, Kupfer S, Rosenberg J, Bocsi G, Hampel H
Gastroenterology
. 2021 Oct;
162(2):360-365.
PMID: 34666049
No abstract available.
10.
Francis J, Harding J, Schram A, Canestraro J, Haggag-Lindgren D, Heinemann M, et al.
JAMA Ophthalmol
. 2021 Sep;
139(10):1126-1130.
PMID: 34473206
Importance: Fibroblast growth factor receptor (FGFR) 1 to 4 inhibitors are approved by the US Food and Drug Administration and suppress the mitogen-activated protein kinase (MAPK) pathway, with a potential...